1. Home
  2. NEWS
  3. Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

December 17, 2021

State of Science at Porosome Therapeutics, Inc.
Porosome reconstitution therapy: A biologic rescue from cystic fibrosis (In human lung organoids and in CF mice)
Porosome Therapeutics Inc, is proud to announce that Company Chairman Prof. Bhanu P. Jena delivered the Commencement Keynote Address to the 2024 Graduating Medical Class at Wayne State University on 6th June, 2024.